Schonfeld Strategic Advisors LLC Arcturus Therapeutics Holdings Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 283,420 shares of ARCT stock, worth $6.58 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
283,420
Previous 346,494
18.2%
Holding current value
$6.58 Million
Previous $11.7 Million
41.02%
% of portfolio
0.05%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding ARCT
# of Institutions
186Shares Held
25.9MCall Options Held
320KPut Options Held
153K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$109 Million0.28% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$61.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.96MShares$45.6 Million0.44% of portfolio
-
Nikko Asset Management Americas, Inc.1.56MShares$36.3 Million0.44% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.56MShares$36.3 Million0.03% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $617M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...